PAB Chart & TA, page-262

Take another look thse who have lost patience.

LDX holders who sold out on 1 June have now missed out on a 1,000% gain!!! THAT'S what happens with Bio's you eithet don't buy, or you just hold and hold and hold. And it's not a CURE for CANCER!!!!

"And Lumos Diagnostics (ASX:LDX) continues to run after yesterday receiving all important FDA clearance for FebriDX, an aid in the diagnosis of bacterial acute respiratory infection.The clearance means it can now be marketed in the US for use by healthcare professionals.The stock is now up 700% since Monday morning."